Compare · CME vs MRX
CME vs MRX
Side-by-side comparison of CME Group Inc. (CME) and Marex Group plc (MRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CME and MRX operate in Investment Bankers/Brokers/Service (Finance), so they compete in similar markets.
- CME is the larger of the two at $101.15B, about 17.4x MRX ($5.80B).
- Over the past year, CME is up 6.1% and MRX is up 118.2% - MRX leads by 112.2 points.
- CME has been more active in the news (10 items in the past 4 weeks vs 8 for MRX).
- CME has more recent analyst coverage (25 ratings vs 12 for MRX).
CME Group Inc.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions. The company also provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services; and transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, regulatory reporting, and trade processing. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company has strategic partnership with B3 S.A. to develop risk management products for Brazilian domestic and international market participants. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Latest CME
- CME Group to Enter European Dairy Market with Transition of EEX Dairy Products
- CME Group Sets New FX Open Interest Record
- CME Group Inc. Announces Third-Quarter 2026 Earnings Release, Conference Call
- CME Group Sets New Open Interest Record in Henry Hub Natural Gas Futures
- CME Group Reports Second-Highest August ADV of 29.7 Million Contracts
- CME Group Opens Registration for 23rd Annual Global University Trading Challenge
- CME Group to Launch E-mini Equity Factor Futures on September 21
- CME Group Enters Wind Market with Contracts Designed for Renewable Energy Hedging
- CME Group Announces First Trade of U.S. Zinc Futures
- CME Group downgraded by Deutsche Bank with a new price target
Latest MRX
- SEC Form 424B3 filed by Marex Group plc
- Officer Tonucci Paolo was granted 38,921 units of Ordinary Shares, increasing direct ownership by 3% to 1,304,530 units (SEC Form 4)
- CEO, Marex Solutions Jethwa Nilesh was granted 67,163 units of Ordinary Shares, increasing direct ownership by 27% to 314,517 units (SEC Form 4)
- Chief Executive Officer Lowitt Ian T was granted 77,843 units of Ordinary Shares, increasing direct ownership by 3% to 2,872,059 units (SEC Form 4)
- President Van Den Born Simon was granted 33,582 units of Ordinary Shares, increasing direct ownership by 2% to 1,498,834 units (SEC Form 4)
- SEC Form S-8 filed by Marex Group plc
- SEC Form S-8 POS filed by Marex Group plc
- Chief Financial Officer Irvin Rob sold $262,545 worth of Ordinary Shares (3,700 units at $70.96), decreasing direct ownership by 11% to 31,046 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Marex Group plc
- SEC Form 13F-HR filed by Marex Group plc